Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-FR Version v1-EN
Language French English
Date Updated 2022-02-09 2021-02-22
Drug Identification Number 00682020 00682020
Brand name ERYTHRO-BASE ERYTHRO-BASE
Common or Proper name Erythro-Base Erythro-Base
Company Name AA PHARMA INC AA PHARMA INC
Ingredients ERYTHROMYCIN ERYTHROMYCIN
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BTL 100BTL
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-22 2021-02-22
Estimated end date 2022-06-28 2021-05-14
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments